CME Group Berhad (KLSE:CME)
0.0150
0.00 (0.00%)
At close: Jun 10, 2026
CME Group Berhad Income Statement
Financials in millions MYR. Fiscal year is October - September.
Millions MYR. Fiscal year is Oct - Sep.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Sep '25 Sep 30, 2025 | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
| 43.29 | 39.93 | 27.22 | 11.76 | 12.14 | 15.96 | |
Revenue Growth (YoY) | 30.01% | 46.69% | 131.52% | -3.12% | -23.94% | 284.92% |
Cost of Revenue | 38.55 | 33.85 | 22.84 | 8.61 | 9.07 | 13.53 |
Gross Profit | 4.74 | 6.09 | 4.38 | 3.15 | 3.07 | 2.42 |
Selling, General & Admin | 3.32 | 3.16 | 3.18 | 2.84 | 2.91 | 2.92 |
Other Operating Expenses | 1.29 | 1.04 | 2.84 | 0.47 | 0.65 | 3.37 |
Operating Expenses | 4.61 | 4.2 | 6.02 | 3.3 | 3.56 | 6.29 |
Operating Income | 0.13 | 1.89 | -1.64 | -0.16 | -0.5 | -3.87 |
Interest Expense | -1.12 | -1.16 | -1.21 | -1.28 | -1.16 | -1.19 |
Interest & Investment Income | - | - | - | - | - | 0.03 |
Currency Exchange Gain (Loss) | - | - | 0.21 | 0.11 | - | 0.11 |
Other Non Operating Income (Expenses) | -0.75 | - | - | 0.01 | 0.09 | - |
EBT Excluding Unusual Items | -1.73 | 0.73 | -2.63 | -1.31 | -1.57 | -4.92 |
Gain (Loss) on Sale of Investments | 0.15 | 0.15 | 0.17 | 0 | -0.06 | - |
Gain (Loss) on Sale of Assets | 0.3 | 0.3 | 0.21 | - | - | - |
Asset Writedown | - | 5.08 | - | - | - | - |
Pretax Income | -1.29 | 6.26 | -2.25 | -1.31 | -1.63 | -4.92 |
Income Tax Expense | -2.15 | -2.15 | 0.25 | 0.14 | - | 0.23 |
Net Income | 0.86 | 8.41 | -2.5 | -1.45 | -1.63 | -5.15 |
Net Income to Common | 0.86 | 8.41 | -2.5 | -1.45 | -1.63 | -5.15 |
Net Income Growth | -85.34% | - | - | - | - | - |
Shares Outstanding (Basic) | 1,236 | 1,181 | 1,044 | 1,021 | 1,007 | 978 |
Shares Outstanding (Diluted) | 1,284 | 1,229 | 1,566 | 1,021 | 1,007 | 978 |
Shares Change (YoY) | -19.66% | -21.51% | 53.30% | 1.44% | 2.99% | -31.42% |
EPS (Basic) | 0.00 | 0.01 | -0.00 | -0.00 | -0.00 | -0.01 |
EPS (Diluted) | 0.00 | 0.01 | -0.00 | -0.00 | -0.00 | -0.01 |
EPS Growth | -82.79% | - | - | - | - | - |
Free Cash Flow | -2.32 | 3.21 | 3.54 | -7.09 | -3.5 | -1.86 |
Free Cash Flow Per Share | -0.00 | 0.00 | 0.00 | -0.01 | -0.00 | -0.00 |
Gross Margin | 10.95% | 15.24% | 16.09% | 26.77% | 25.25% | 15.17% |
Operating Margin | 0.30% | 4.72% | -6.01% | -1.32% | -4.09% | -24.25% |
Profit Margin | 1.99% | 21.05% | -9.19% | -12.32% | -13.45% | -32.27% |
Free Cash Flow Margin | -5.36% | 8.04% | 13.00% | -60.32% | -28.87% | -11.68% |
EBITDA | 0.32 | 2.07 | -1.27 | 0.19 | -0.29 | -3.49 |
EBITDA Margin | 0.73% | 5.18% | -4.65% | 1.64% | -2.42% | -21.87% |
D&A For EBITDA | 0.19 | 0.18 | 0.37 | 0.35 | 0.2 | 0.38 |
EBIT | 0.13 | 1.89 | -1.64 | -0.16 | -0.5 | -3.87 |
EBIT Margin | 0.30% | 4.72% | -6.01% | -1.32% | -4.09% | -24.25% |